IRIS Accounts Production v23.3.1.45 11866816 director 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118668162022-03-31118668162023-03-31118668162022-04-012023-03-31118668162021-03-31118668162021-04-012022-03-31118668162022-03-3111866816ns10:Originalns15:EnglandWales2022-04-012023-03-3111866816ns14:PoundSterlingns10:Original2022-04-012023-03-3111866816ns10:Originalns10:Director12022-04-012023-03-3111866816ns10:Original2022-04-012023-03-3111866816ns10:Original2023-03-3111866816ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111866816ns10:Originalns10:SmallEntities2022-04-012023-03-3111866816ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111866816ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111866816ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3111866816ns10:Originalns10:AbridgedAccounts2022-04-012023-03-3111866816ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3111866816ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111866816ns10:Original2022-03-3111866816ns10:Originalns5:CurrentFinancialInstruments2023-03-3111866816ns10:Originalns5:CurrentFinancialInstruments2022-03-3111866816ns5:ShareCapitalns10:Original2023-03-3111866816ns5:ShareCapitalns10:Original2022-03-3111866816ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3111866816ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3111866816ns10:Originalns5:ComputerEquipment2022-04-012023-03-3111866816ns10:Original2021-04-012022-03-3111866816ns10:Original2022-03-3111866816ns10:Originalns10:OrdinaryShareClass12023-03-3111866816ns10:Original1ns10:Director12022-03-3111866816ns10:Original1ns10:Director12021-03-3111866816ns10:Original1ns10:Director12022-04-012023-03-3111866816ns10:Original1ns10:Director12021-04-012022-03-3111866816ns10:Original1ns10:Director12023-03-3111866816ns10:Original1ns10:Director12022-03-31
REGISTERED NUMBER: 11866816 (England and Wales)
























UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

FOR

A F NEUROLOGY LIMITED

A F NEUROLOGY LIMITED (REGISTERED NUMBER: 11866816)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


A F NEUROLOGY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTOR: Dr A Foutsitzi



REGISTERED OFFICE: Pavey Ark
Brantfell Road
Bowness-on-Windermere
Cumbria
LA23 3AE



REGISTERED NUMBER: 11866816 (England and Wales)



BANKERS: HSBC Bank plc
104 Duke Street
Barrow in Furness
Cumbria
LA14 1LR

A F NEUROLOGY LIMITED (REGISTERED NUMBER: 11866816)

ABRIDGED BALANCE SHEET
31 MARCH 2023

31.3.23 31.3.22
Notes £    £   
CURRENT ASSETS
Debtors 34,131 41,874
Cash at bank 42 467
34,173 42,341
CREDITORS
Amounts falling due within one year 3,254 7,272
NET CURRENT ASSETS 30,919 35,069
TOTAL ASSETS LESS CURRENT
LIABILITIES

30,919

35,069

CAPITAL AND RESERVES
Called up share capital 5 1 1
Retained earnings 30,918 35,068
SHAREHOLDERS' FUNDS 30,919 35,069

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 February 2024 and were signed by:





Dr A Foutsitzi - Director


A F NEUROLOGY LIMITED (REGISTERED NUMBER: 11866816)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. STATUTORY INFORMATION

A F Neurology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2022
and 31 March 2023 449
DEPRECIATION
At 1 April 2022
and 31 March 2023 449
NET BOOK VALUE
At 31 March 2023 -
At 31 March 2022 -

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
1 Ordinary £1 1 1

A F NEUROLOGY LIMITED (REGISTERED NUMBER: 11866816)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

6. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2023 and 31 March 2022:

31.3.23 31.3.22
£    £   
Dr A Foutsitzi
Balance outstanding at start of year 41,873 43,342
Amounts advanced 34,130 41,873
Amounts repaid (41,873 ) (43,342 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 34,130 41,873

During the period to 31st March 2023, interest of £752 has been charged (2022: £843). The loan is repayable on demand.

7. ULTIMATE CONTROLLING PARTY

The controlling party is Dr A Foutsitzi.